Become A Featured Company

Cannabis Users Drive High, and Crashes Are on the Rise

Robin Lefferts

December 14th, 2018

Exclusive, Top Story

As cannabis legalization spreads across North America, there is a growing realization of the public safety issues surrounding widespread use of the legalized drug. Even cannabis consumers admit that driving under the influence of marijuana can be dangerous, but in general they do it anyway. Public health officials have launched educational campaigns, but the entrenched idea among cannabis users that the drug is not as dangerous as alcohol is hard to overcome. Add to that the technical difficulties surrounding the testing of THC levels and impairment, and it is easy to see why public health officials see a safety crisis that only promises to grow before practical solutions can be found.

Cannabix Technologies, Inc. (CSE: BLO) (OTC: BLOZF) (8CT: FRA) is advancing a marijuana breathalyzer the company hopes will solve a major part of the current cannabis safety issue. By providing a reliable and convenient roadside testing solution, Cannabix hopes to give law enforcement and employers the tools they currently lack to accurately determine recent marijuana use at the point of care. Combined with continued public education, such a tool could clear up a lot of the grey areas currently surrounding the issue of driving under the influence of legal cannabis and help keep our roads safer.

The Statistics

A study by the Colorado Department of Transportation, released earlier in 2018, found that 69% of marijuana users had driven under the influence in the year prior, with 27% indicating they drove under the influence almost daily. North of the border, the findings are significant as well. Health Canada’s annual Canadian Cannabis Survey found that 39% of marijuana users reported having driven within 2 hours of using the drug, with 43% of those people having driven under the influence in the last 30 days. Clearly, the public safety message is not getting through to a preponderance of cannabis users.

Meanwhile, the Insurance Institute for Highway Safety and Highway Loss Data Institute recently released two studies showing that vehicle crashes rose between 5% and 6% in states that legalized cannabis use, compared to neighboring states that did not legalize. In the linked article, the IIHS notes that “Marijuana’s role in crashes isn’t as clear as the link between alcohol and crashes. Many states don’t include consistent information on driver drug use in crash reports, and policies and procedures for drug testing are inconsistent. More drivers in crashes are tested for alcohol than for drugs.”

In a Las Vegas-area report on the issue, retired Las Vegas lieutenant Randy Sutton lamented the lack of tools to accurately measure marijuana impairment. “Marijuana is a different story,” said Sutton. “Tests to determine someone’s impairment are more guesswork than they are science.” At the same time, Sutton noted the increase of impaired drivers on the road resulting from cannabis legalization.

Tools Needed to Combat the Dangers

Along with a robust educational campaign to change public perceptions and behaviors regarding cannabis use and driving, proper tools are needed to accurately and conveniently identify THC levels in potentially impaired drivers. Mr. Sutton’s lament is a common refrain for law enforcement and public health officials. With invasive, inconsistent, and slow saliva tests being tested, there is a distinct need for the cannabis equivalent of the alcohol breathalyzer.

All of these issues could be alleviated with the introduction of a portable Cannabix Marijuana Breathalyzer. Cannabix is using mass spectrometry (MS) related technology known as field asymmetric waveform ion mobility spectrometry (FAIMS) to ensure accuracy of THC detection from human breath. Cannabix is a well-funded company that has been steadily developing its prototype breathalyzer, advancing its technology to bring the device to market as soon as possible, with research and pilot testing and other milestones ahead.

Cannabis legalization is on the rise and cannabis impaired driving showsno signs of letting up. With current technologies lacking, the introduction of a cannabis breathalyzer could be a game-changer. Stay tuned for further developments.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Robin Lefferts

Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading